Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Histiocytoma, Malignant Fibrous × eribulin × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 13 Triple Negative Breast Neoplasms 6 Neoplasm Metastasis 3 Urinary Bladder Neoplasms 2 Urethral Neoplasms 1 Ureteral Neoplasms 1 Recurrence 1 Hemangiosarcoma 1 Hemangioendothelioma, Epithelioid 1 HER2-low Breast Cancer 1 Carcinoma, Transitional Cell 1 Brest Cancer 1 Brain Neoplasms 1

Interventions

pembrolizumab 2 Specimen Handling 2 Radiotherapy 2 Radiation 2 Doxorubicin 2 talimogene laherparepvec 1 regorafenib 1 pazopanib 1 futibatinib 1 X-Rays 1 Trabectedin 1 Standard of Care 1 Quality of Life 1 Magnetic Resonance Spectroscopy 1 Ifosfamide 1 Erlotinib Hydrochloride 1 Dactinomycin 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡